The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...
The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas. KJ Muldoon is walking and getting ready to celebrate ...
SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base ...
A baby born with a rare and life-threatening genetic disorder has taken his first steps after receiving a groundbreaking, ...
Lifetime's bombshell docuseries 'Surviving R. Kelly' premiered to acclaim in 2019, but behind the scenes, the original, nearly all-Black postproduction group protested the project's direction and ...
SAN FRANCISCO—Prime Medicine is on track to file the first IND/CTA application for human trials of a prime editing therapy to the FDA during the first half of this year, with the first clinical data ...
Jackson Ryan was CNET's science editor, and a multiple award-winning one at that. Earlier, he'd been a scientist, but he realized he wasn't very happy sitting at a lab bench all day. Science writing, ...
The first CRISPR gene-editing drug, designed to treat blood disorders, could be on the market by 2023. Here’s what it means for the future of drug development. Until recently, CRISPR—the gene-editing ...
There's new hope this week for people who suffer from sickle cell disease. The Food and Drug Administration approved the first genetic treatments for the brutal blood disorder on Friday. The ...
VSCO is a brand well-known among photographers who take advantage of its presets for desktop and its mobile app featuring film-inspired filters and pro image tools. Now the company is moving into ...
The ability to edit genes has raised the prospect of treating genetic conditions and arming the body to better handle infectious diseases and cancers. But for that potential to be realized, we need to ...
A 16-month-old boy, KJ Muldoon, took his first steps after receiving a groundbreaking, personalized CRISPR gene-editing therapy for a rare genetic disorder. This experimental treatment, the first of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback